Viewing Study NCT00516802


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-12 @ 12:32 AM
Study NCT ID: NCT00516802
Status: COMPLETED
Last Update Posted: 2009-05-15
First Post: 2007-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2007-08-13
First Submit QC Date: None
Study First Post Date: 2007-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-05-14
Last Update Post Date: 2009-05-15
Last Update Post Date Type: ESTIMATED